doi: 10.1016/j.pbb.2021.173243 51 GriffinSMPickardMROrmeRPHawkinsCPFrickerRA
Some evidence also suggests that GLP-1 RAs mitigate kidney function loss, especially in patients with evidence of kidney disease [12, 16], and this subject is being formally tested in the FLOW trial [17]
In addition, the protective effects of both a recombinant adiponectin injection in ob/ob mice and metformin administration against NAFLD have been attributed, at least in part, to the inhibition of hepatic TNF expression 24,25
In rare instances, an injection of cortisone may be used to try to control pain
However, to date, information on microbiota-associated GRP metabolism is insufficient